ADA Scientific Sessions 2025 Abstract

MET-097: Preclinical Characterization of a Potent and Ultra-Long-Acting GLP-1 Receptor Agonist

By Charlotte E. Hinds, James S. Minnion, Georgia Zoumpoulidou

Experiments in animalsInterventions

The paper

Charlotte E. Hinds, James S. Minnion, Georgia Zoumpoulidou

London

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 794-P

doi.org/10.2337/db25-794-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice